Bajaj Healthcare has informed that it attached business updates on successfully entering a definitive CDMO agreement with esteemed UK/EU based customers for the supply of 15 Active Pharmaceutical Ingredient (APIs).
The above information is a part of company’s filings submitted to BSE.